[1]

Mao YT, Chen B, Wang HF, et al. Diagnostic performance of magnetic resonance imaging for colorectal liver metastasis: a systematic review and meta-analysis[J/OL]. Sci Rep, 2020, 10(1): 1969[2020-03-07]. https://www.nature.com/articles/s41598-020-58855-1. DOI: 10.1038/s41598-020-58855-1.
[2] Chakedis J, Squires MH, Beal EW, et al.  Update on current problems in colorectal liver metastasis[J]. Curr Probl Surg, 2017, 54(11): 554-602.   doi: 10.1067/j.cpsurg.2017.10.002
[3] Jones RP, Kokudo N, Folprecht G, et al.  Colorectal liver metastases: a critical review of state of the art[J]. Liver Cancer, 2016, 6(1): 66-71.   doi: 10.1159/000449348
[4]

Engstrand J, Nilsson H, Strömberg C, et al. Colorectal cancer liver metastases — a population-based study on incidence, management and survival[J/OL]. BMC Cancer, 2018, 18(1): 78[2020-03-07]. https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3925-x. DOI: 10.1186/s12885-017-3925-x.
[5]

Gurusamy K, Corrigan N, Croft J, et al. Liver resection surgery versus thermal ablation for colorectal liver metastases (LAVA): study protocol for a randomised controlled trial[J/OL]. Trials, 2018, 19(1): 105[2020-03-07]. https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-018-2499-5. DOI: 10.1186/s13063-018-2499-5.
[6] Okuno M, Hatano E, Nishino H, et al.  Does response rate of chemotherapy with molecular target agents correlate with the conversion rate and survival in patients with unresectable colorectal liver metastases?: a systematic review[J]. Eur J Surg Oncol, 2017, 43(6): 1003-1012.   doi: 10.1016/j.ejso.2016.08.019
[7] Beiderwellen K, Gomez B, Buchbender C, et al.  Depiction and characterization of liver lesions in whole body 18F-FDG PET/MRI[J]. Eur J Radiol, 2013, 82(11): e669-e675.   doi: 10.1016/j.ejrad.2013.07.027
[8]

Kirchner J, Sawicki LM, Deuschl C, et al. 18F-FDG PET/MR imaging in patients with suspected liver lesions: value of liver-specific contrast agent Gadobenate dimeglumine[J/OL]. PLoS One, 2017, 12(7): e0180349[2020-03-07]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0180349. DOI: 10.1371/journal.pone.0180349.
[9] Lee DH, Lee JM, Hur BY, et al.  Colorectal cancer liver metastases: diagnostic performance and prognostic value of PET/MR imaging[J]. Radiology, 2016, 280(3): 782-792.   doi: 10.1148/radiol.2016151975
[10] Lee KH, Lee JM, Park JH, et al.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid[J]. Korean J Radiol, 2013, 14(6): 894-904.   doi: 10.3348/kjr.2013.14.6.894
[11] 谭继初, 曾鹏程, 陶辉, 等.  结直肠癌肝转移瘤的CT成像特点及规律分析[J]. 广州医药, 2019, 50(1): 64-67.   doi: 10.3969/j.issn.1000-8535.2019.01.016
Tan JC, Zeng PC, Tao H, et al.  CT imaging features and regularity analysis of colorectal cancer liver metastases[J]. Guangzhou Med J, 2019, 50(1): 64-67.   doi: 10.3969/j.issn.1000-8535.2019.01.016
[12] Morsing A, Hildebrandt MG, Vilstrup MH, et al.  Hybrid PET/MRI in major cancers: a scoping review[J]. Eur J Nucl Med Mol Imaging, 2019, 46(10): 2138-2151.   doi: 10.1007/s00259-019-04402-8
[13] Ishii S, Shimao D, Hara T, et al.  Comparison of integrated whole-body PET/MR and PET/CT: is PET/MR alternative to PET/CT in routine clinical oncology?[J]. Ann Nucl Med, 2016, 30(3): 225-233.   doi: 10.1007/s12149-015-1050-y
[14] Maffione AM, Lopci E, Bluemel C, et al.  Diagnostic accuracy and impact on management of 18F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review[J]. Eur J Nucl Med Mol Imaging, 2015, 42(1): 152-163.   doi: 10.1007/s00259-014-2930-4
[15] Brendle C, Schwenzer NF, Rempp H, et al.  Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series[J]. Eur J Nucl Med Mol Imaging, 2016, 43(1): 123-132.   doi: 10.1007/s00259-015-3137-z
[16] Berger KL, Nicholson SA, Dehdashti F, et al.  FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features[J]. AJR Am J Roentgenol, 2000, 174(4): 1005-1008.   doi: 10.2214/ajr.174.4.1741005
[17] Nasu K, Kuroki Y, Minami M.  Diffusion-weighted imaging findings of mucinous carcinoma arising in the ano-rectal region: comparison of apparent diffusion coefficient with that of tubular adenocarcinoma[J]. Jpn J Radiol, 2012, 30(2): 120-127.   doi: 10.1007/s11604-011-0023-x
[18] Donati OF, Hany TF, Reiner CS, et al.  Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI[J]. J Nucl Med, 2010, 51(5): 692-699.   doi: 10.2967/jnumed.109.068510
[19]

Beiderwellen K, Geraldo L, Ruhlmann V, et al. Accuracy of [18F]FDG PET/MRI for the detection of liver metastases[J/OL]. PLoS One, 2015, 10(9): e0137285[2020-03-07]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0137285. DOI: 10.1371/journal.pone.0137285.
[20] Hong SB, Choi SH, Kim KW, et al.  Diagnostic performance of [18F]FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis[J]. Eur Radiol, 2019, 29(7): 3553-3563.   doi: 10.1007/s00330-018-5909-x
[21] 张占文, 吕清湖, 陈斐妮, 等.  18氟-脱氧葡萄糖正电子发射计算机断层成像联合同机增强CT对结直肠癌肝转移的诊断价值[J]. 中华胃肠外科杂志, 2015, 18(3): 238-242.   doi: 10.3760/cma.j.issn.1671-0274.2015.03.009
Zhang ZW, Lyu QH, Chen FN, et al.  Diagnostic value of 18F-fluorodexyglucose positron emission tomography combined with contrast enhanced computed tomography in colorectal cancer liver metastasis[J]. Chin J Gastrointest Surg, 2015, 18(3): 238-242.   doi: 10.3760/cma.j.issn.1671-0274.2015.03.009
[22] 梁家绪, 周依, 贺祥.  Gd-EOB-DTPA MRI增强和Gd-EOB-DTPA MRI增强联合DWI对结直肠癌肝转移诊断价值比较的meta分析[J]. 河南医学研究, 2019, 28(22): 4036-4041.   doi: 10.3969/j.issn.1004-437X.2019.22.002
Liang JX, Zhou Y, He X.  Comparison of Gd-EOB-DTPA-enhanced MRI combined with DWI and Gd-EOB-DTPA-enhanced MRI along in detection of colorectal cancer liver metastases: a meta analysis[J]. Henan Med Research, 2019, 28(22): 4036-4041.   doi: 10.3969/j.issn.1004-437X.2019.22.002
[23] 毛武剑, 石洪成.  18F-FDG PET/CT在结直肠癌肝转移诊治中的应用价值[J]. 中华核医学与分子影像杂志, 2019, 39(9): 560-563.   doi: 10.3760/cma.j.issn.2095-2848.2019.09.014
Mao WJ, Shi HC.  Value of 18F-FDG PET/CT in the diagnosis and treatment of colorectal cancer liver metastases[J]. Chin J Nucl Med Mol Imaging, 2019, 39(9): 560-563.   doi: 10.3760/cma.j.issn.2095-2848.2019.09.014